Skip to main content
. 2015 Mar 2;48(1):312–321. doi: 10.4143/crt.2014.266

Fig. 1.

Fig. 1.

Study design: cross-sectional analysis. This prospective cohort study aimed to develop a predictive model for treatment outcomes and treatment-related morbidity (such as VTE in this study) in patients with lymphoma. VTE, venous thromboembolism; DLBCL, diffuse large B-cell lymphoma; LDH, lactate dehydrogenase; IPI, International Prognostic Index; CRP, C-reactive protein.